Inflammatory markers in Alzheimer's disease and vascular dementia

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 113, Issue 2, 2013, Pages 49-55

  Androsova, L V ^a   Mikhailova, N M ^a   Zozulya, S A ^a   Dupin, A M ^a   Rassadina, G A ^b   Lavrent'eva, N V ^a   Kliushnik, T P ^a  

^a MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^b Moscow City Oncology Hospital   (Russian Federation)

Author keywords

Alpha 1 proteinase inhibitor; Alzheimer's disease; IL 6; Leukocyte elastase; Markers of inflammation; Vascular dementia

Indexed keywords

ALPHA 1 ANTITRYPSIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEUKOCYTE ELASTASE;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA;

EID: 84922687559     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Russian Source
2. Russian Source
3. Russian Source
4. Russian Source
5. Russian Source
6. Angelopoulos P., Agouridaki H., Vaiopoulos H., Siskou E., Doutsou K., et al. Cytokines in Alzheimer's disease and vascular dementia. Int J Neurosci 2008; 118: 12: 1659-1672.
7. Azzolina A., Bongiovanni A., Lampiasi N. Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochim Biophys Acta 2003; 1643: 1-3: 75-83.
8. Baugh R.J., Travis J. Human leukocyte granule elastase: rapid isolation and characterization. Biochemistry 1976; 15: 4: 836-841.
9. Coil J., Tam E., Waterfield J.D. Proinflammatory cytokine profiles in pulp fibroblasts stimulated with lipopolysaccharide and methyl mercaptan. J En-dod 2004; 30: 2: 88-91.
10. Eriksson U.K., Pedersen N.L., Reynolds C.A., Hong M.-G., Prince J.A., Gatz M., Dickman P. W., Bennet A.M. Associations of gene sequence variation and serum levels of C-reactive protein and Interleukin-6 with Alzheimer's disease and dementia. J Alzheimers Dis 2011; 23: 2: 361-369.
11. Folstein M.F., Folstein S.F., McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psy-chiat Res 1975; 12: 189-198.
12. Galimberti D., Scarpini E. Inflammation and oxidative damage in Alzheimer's disease: friend or foe? Front Biosci 2011; 3: 252-266.
13. Glass Ch. K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms underlying inflammation in neurodegeneration. Cell 2010; 140: 6: 918-934.
14. Hickman S.E., Allison E.K., El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 2008; 28: 33: 8354-8360.
15. Hoenstein R., Admon D., Solomon A., Norris A., Moqbel R., Levi-Schaffer F. Interleukin-2 activates human peripheral blood eosinophils. Cell Immunol 2001; 210: 2: 116-124.
16. Holmes C., Cunningham C., Zotova E., Culliford D., Perry V.H. Proinflam-matory cytokines, sickness behavior, and Alzheimer disease. Neurology 2011; 77: 3: 212-218.
17. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. A new clinical scale for the staging of dementia. Br J Psychiatr 1982; 140: 3: 566-572.
18. Inoue K. Microglial activation by purines and pyrimidines. Glia 2002; 40: 2: 156-163.
19. Ionescu C.V., Cepinskas G., Savickiene J., Sandig M., Kvietys P.R. Neutro-phils induce sequential focal changes in endothelial adherens junction components: role of elastase. Microcirculation 2003; 10: 2: 205-220.
20. Jialal I., Devaraj S., Venugopal S.K. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 2004; 44: 1: 6-11.
21. Katunuma N., Suzuki K., Tranis J., Fritz H. Baset Japan Scientific Societies press. Kager 1994; 274.
22. Kuller L.H., Lopez O.L. Dementia and Alzheimer's disease: A new direction. The 2010 L. Jay Foster Memorial Lecture. Alzheimer's Dement 2011; 7: 5: 540-550.
23. Kushner J., Gewurz H., Benson M. C-reactive protein and acute-phase response. J Lab Clin Med 1981; 97: 6: 739-749.
24. Kushner I., Jiang S.L., Zhang D., Lozanski G., Samols D. Do post-transcrip-tional mechanisms participate in induction of C-reactive protein and serum amyloid A by IL-6 and IL-1? Ann NY Acad Sci 1995; 762: 102-107.
25. Kuta A.E., Baum L.L. C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes. J Exp Med 1986; 164: 1: 321-326.
26. Licastro F., Morini M.C., Polazzi E., Davis L.J. Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response. J Neuroimmunol 1995; 57: 1-2: 71-75.
27. McGeer E.G., McGeer P.L. The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol 1998; 33: 5: 371-378.
28. Mckhann G., Drachman D., Folstein M. et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 7: 939-944.
29. Oztürk and #xF840;., Ozge A., Yalin O.O., Yilmaz I.A., Delialioglu N. et al. The diagnostic role of serum inflammatory and soluble proteins on dementia subtypes: correlations with cognitive and functional decline. Behav Neurol 2007; 18: 4: 207-215.
30. Richartz E., Stransky E., Batra A., Simon P., Lewczuk P., Buchkremer G., Bartels M., Schott K. Decline of immune responsiveness: a pathogeneticfactor in Alzheimer's disease? J Psychiatr Res 2005; 39: 5: 535-543.
31. Román G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 2: 250-260.
32. Singh V.K., Guthikonda P. Circulating cytokines in Alzheimer's disease. J Psychiatr Res 1997; 31: 6: 657-660.
33. Soderquist B., Kallman J., Holmberg H., Vikerfors T., Kihlstrom E. Secretion of IL-6, IL-8 and G-CSF by human endothelial cells in vitro in response to Staphylococcus aureus and staphylococcal exotoxins. APMIS 1998; 106: 12: 1157-1164.
34. Thake C.D., Mian T., Garnham A.W., Mian R. Leukocyte counts and neutrophil activity during 4 h of hypocapnic hypoxia equivalent to 4000 m. Aviat Space Environ Med 2004; 75: 9: 811-817.
35. Tohgi H., Takahashi H., Tamura K., Konno S., Kawamorita A., Nozaki Y. Ischemic stroke among inpatients with preceding inflammatory response. Thromb Res 2001; 104: 5: 375-377.
36. Topham M.K., Carveth H.J., McIntyre T.M., Prescott S.M., Zimmerman G.A. Human endothelial cells regulate polymorphonuclear leukocyte degranulation. FASEB J 1998; 12: 9: 733-746.
37. Town T. Inflammation, immunity, and Alzheimer's disease. CNS Neurol Disord Drug Targets 2010; 9: 2: 129-131.
38. van Duijn C.M., Hofman A., Nagelkerken L. Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease. Neurosci Lett 1990; 108: 3: 350-354.
39. Verma S., Yeh E.T. C-reactive protein and atherothrombosis-beyond a biomarker: an actual partaker of lesion formation. Am J Physiol Regul Integr Comp Physiol 2003; 285: 5: 1253-1256.
40. Wang S., Wang R., Chen L., Bennett D.A., Dickson D.W., Wang D.S. Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain. J Neurochem 2010; 115: 1: 47-57.
41. Zuliani G., Ranzini M., Guerra G., Rossi L. et al. Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia. J Psychiatr Res 2007; 41: 8: 686-693.